Your browser doesn't support javascript.
loading
Characterization and Clinical Assessment of a Peculiar Case of Hemolytic Anemia.
Castelgrande, Fulvio; Viola, Gemma; Calabrese, Cinzia; Iozzo, Mariannina; Massoud, Renato; Pieri, Massimo; Minieri, Marilena; Adorno, Gaspare; Bernardini, Sergio; Terrinoni, Alessandro.
Afiliação
  • Castelgrande F; School of Laboratory Medicine and Pathology, University of Rome Tor Vergata, Via Cracovia, 00133 Rome, Italy.
  • Viola G; These three authors contributed to the study equally.
  • Calabrese C; Laboratory Medicine Department, University Hospital of Tor Vergata, Viale Oxford, 1-00133 Rome, Italy.
  • Iozzo M; These three authors contributed to the study equally.
  • Massoud R; School of Laboratory Medicine and Pathology, University of Rome Tor Vergata, Via Cracovia, 00133 Rome, Italy.
  • Pieri M; These three authors contributed to the study equally.
  • Minieri M; Laboratory Medicine Department, University Hospital of Tor Vergata, Viale Oxford, 1-00133 Rome, Italy.
  • Adorno G; Laboratory Medicine Department, University Hospital of Tor Vergata, Viale Oxford, 1-00133 Rome, Italy.
  • Bernardini S; Department of Experimental Medicine, University of Rome Tor Vergata, Via Montpellier, 1-00133 Rome, Italy.
  • Terrinoni A; Laboratory Medicine Department, University Hospital of Tor Vergata, Viale Oxford, 1-00133 Rome, Italy.
J Hematol ; 13(3): 108-115, 2024 Jun.
Article em En | MEDLINE | ID: mdl-38993732
ABSTRACT
Thalassemic diseases are characterized by a reduced (ß+) or absent (ß0) synthesis of the globin chains of hemoglobin (Hb) due to genetic mutations. ß-thalassemia was more frequent in the Mediterranean area, but now it is diffused worldwide. Three possible genetic forms can be distinguished ß0/ß0, the most severe (Cooley's disease); ß0/ß+ of intermediate severity; ß+/ß+ associated with ß-thalassemia intermedia or minor. Recently, a clinical non-genetic classification has been proposed transfusion-dependent thalassemia (TDT), requiring regular lifetime blood transfusions, and non-transfusion-dependent thalassemia (NTDT), requiring occasional transfusions to manage acute cases. In this report, we studied a patient whose blood count indicated a severe anemia but also showed thrombocytosis, leukocytosis, and an elevated number of nucleated red blood cells (NRBC). These altered blood parameters suggested initially a possible diagnosis of hemoglobinopathy or myeloproliferative syndrome. The molecular and genetic analyses demonstrated the presence of HbF (5.3%) and HbA2 (7.7%) and the presence of the homozygote mutation (IVS1.6T>C) in the ß-globin gene. According to these data, a diagnosis of ß-thalassemia intermedia form has been proposed. Nevertheless, the clinical condition, the presence of thrombocytosis, leukocytosis, an elevated number of NRBC, and the frequent blood transfusions lead to reclassification of the patient as TDT subject. Consequently, this result suggests that a unique genotype-phenotype correlation is not possible in the presence of ß+mutations since other concomitant pathologies can exacerbate the disease.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article